José Mayordomo - Concepedia

Author

José Mayordomo

Also Known As

J I Mayordomo, J Mayordomo, J. I. Mayordomo, J. I. Mayordomo MD, J. Mayordomo, J.I Mayordomo, J.I. MAYORDOMO, J.I. Mayordomo, JOSE I. MAYORDOMO, Jose I Mayordomo

231

Publications

18.8K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen deCODE Genetics (Iceland)Universidad de Zaragoza National University Hospital of Iceland Hospital Clínico Universitario Lozano Blesa

About

José Mayordomo is an author at Radboud University Nijmegen specializing in medicine, cancer research, and cancer genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	55	13.3K
2	Health Sciences	6	6	1.7K
3	Public Health	4	4	428
4	Engineering	1	1	10
5	Biochemistry	1	1	12

José Mayordomo

Publications

17.6K

Citations

H-Index

Page 1

	Year	Citations
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease Thorgeir E. Thorgeirsson, Frank Geller, Patrick Sulem, Nature Tobacco CessationTobacco ControlTobacco UseAddictionNicotine	2008	1.5K
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity José Mayordomo, Tatiana Zorina, Walter J. Storkus, Nature Medicine Marrow-derived Dendritic CellsTumor ImmunologyTherapeutic Antitumour ImmunityImmunologyTumor Immunity	1995	1.1K
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Patrick Sulem, Andrei Manolescu, Laufey T. Ámundadóttir, Nature Genetics Genome-wide Association StudyUrologyGeneticsGenetic EpidemiologyCancer Genomics	2007	865
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. Laurence Zitvogel, José Mayordomo, Tjendimin Tjandrawan, The Journal of Experimental Medicine Host Dendritic CellsImmunologyImmunoeditingMurine TumorsCd4 T Cell Responses	1996	843
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer Simon Stacey, Andrei Manolescu, Patrick Sulem, Nature Genetics Breast OncologyConfer SusceptibilityChromosomes 2Q35GeneticsMedicine	2007	784
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. Christina M. Celluzzi, José Mayordomo, Walter J. Storkus, The Journal of Experimental Medicine Tumor ImmunologyCancer ImmunosurveillanceCytotoxic TMedicineImmunology	1996	732
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Patrick Sulem, Valgerður Steinthórsdóttir, Andrei Manolescu, Nature Genetics Tcf2 ProtectsUrologyGenetic DeterminantGeneticsGenetic Epidemiology	2007	722
Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior Thorgeir E. Thorgeirsson, Daníel F. Guðbjartsson, Ida Surakka, Nature Genetics Long Non-coding RnaGeneticsSequence VariantsGene Expression	2010	692
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer José Baselga, Peter van Dam, Alexey Manikhas, Journal of Clinical Oncology	2009	658
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types Patrick Sulem, Simon Stacey, Frank Geller, Nature Genetics Somatic VariantSequence VariantsTumor HeterogeneityGeneticsPathology	2009	608

Page 1